Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12616107

Download in:

View as

General Info

PMID
12616107